Global Covid-19 Therapeutic Market Size, Status and Forecast 2020-2026


This report focuses on the global Covid-19 Therapeutic status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Covid-19 Therapeutic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
    Cadila Healthcare
    Johnson & Johnson
    ImmunoPrecise
    Novartis
    AstraZeneca
    Cipla
    AbbVie
    Bayer
    Regeneron Pharmaceuticals
    Ascletis Pharma
    GlaxoSmithKline
    Gilead Sciences
    Pharmstandard
    Fujifilm Holdings
    Zhejiang Hisun Pharmaceutical Co. Ltd
    Roche
    Sanofi
    Pfizer

Market segment by Type, the product can be split into
    Immunotherapy
    Life Support
    Antiviral Medicine
    Plasma Therapy
    Others
Market segment by Application, split into
    Children
    Adult

Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Covid-19 Therapeutic status, future forecast, growth opportunity, key market and key players.
    To present the Covid-19 Therapeutic development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Covid-19 Therapeutic are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered: Ranking by Covid-19 Therapeutic Revenue
    1.4 Covid-19 Implications on Market by Type
        1.4.1 Global Covid-19 Therapeutic Market Size Growth Rate by Type: 2020 VS 2026
        1.4.2 Immunotherapy
        1.4.3 Life Support
        1.4.4 Antiviral Medicine
        1.4.5 Plasma Therapy
        1.4.6 Others
    1.5 Covid-19 Implications on Market by Application
        1.5.1 Global Covid-19 Therapeutic Market Share by Application: 2020 VS 2026
        1.5.2 Children
        1.5.3 Adult
    1.6 Coronavirus Disease 2019 (Covid-19): Covid-19 Therapeutic Industry Impact
        1.6.1 How the Covid-19 is Affecting the Covid-19 Therapeutic Industry
            1.6.1.1 Covid-19 Therapeutic Business Impact Assessment - Covid-19
            1.6.1.2 Supply Chain Challenges
            1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
        1.6.2 Market Trends and Covid-19 Therapeutic Potential Opportunities in the COVID-19 Landscape
        1.6.3 Measures / Proposal against Covid-19
            1.6.3.1 Government Measures to Combat Covid-19 Impact
            1.6.3.2 Proposal for Covid-19 Therapeutic Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
    2.1 Covid-19 Implications on Global Covid-19 Therapeutic Market Perspective (2015-2026)
    2.2 Covid-19 Implications on Global Covid-19 Therapeutic Growth Trends by Regions
        2.2.1 Covid-19 Therapeutic Market Size by Regions: 2015 VS 2020 VS 2026
        2.2.2 Covid-19 Therapeutic Historic Market Share by Regions (2018-2019)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Covid-19 Implications on Competition Landscape by Key Players
    3.1 Covid-19 Therapeutic Revenue by Players (2019-2020)
    3.2 Covid-19 Therapeutic Key Players Head office and Area Served
    3.3 Key Players Covid-19 Therapeutic Product/Solution/Service
    3.4 Date of Enter into Covid-19 Therapeutic Market
    3.5 Key Players Covid-19 Therapeutic Funding/Investment Analysis
    3.6 Global Key Players Covid-19 Therapeutic Valuation & Market Capitalization
    3.7 Mergers & Acquisitions, Expansion Plans

4 Global Covid-19 Therapeutic Market Size by Type (2019-2026)

5 Global Covid-19 Therapeutic Market Size by Application (2019-2026)

6 North America
    6.1 North America Covid-19 Therapeutic Market Forecast (2019-2026)
    6.2 Covid-19 Therapeutic Key Players in North America (2019-2020)
    6.3 North America Covid-19 Therapeutic Market Size by Type (2015-2020)
    6.4 North America Covid-19 Therapeutic Market Size by Application (2015-2020)

7 Europe
    7.1 Europe Covid-19 Therapeutic Market Forecast (2019-2026)
    7.2 Covid-19 Therapeutic Key Players in Europe (2019-2020)
    7.3 Europe Covid-19 Therapeutic Market Size by Type (2015-2020)
    7.4 Europe Covid-19 Therapeutic Market Size by Application (2015-2020)

8 China
    8.1 China Covid-19 Therapeutic Market Forecast (2019-2026)
    8.2 Covid-19 Therapeutic Key Players in China (2019-2020)
    8.3 China Covid-19 Therapeutic Market Size by Type (2015-2020)
    8.4 China Covid-19 Therapeutic Market Size by Application (2015-2020)

9 Japan
    9.1 Japan Covid-19 Therapeutic Market Forecast (2019-2026)
    9.2 Covid-19 Therapeutic Key Players in Japan (2019-2020)
    9.3 Japan Covid-19 Therapeutic Market Size by Type (2015-2020)
    9.4 Japan Covid-19 Therapeutic Market Size by Application (2015-2020)

10 Southeast Asia
    10.1 Southeast Asia Covid-19 Therapeutic Market Forecast (2019-2026)
    10.2 Covid-19 Therapeutic Key Players in Southeast Asia (2019-2020)
    10.3 Southeast Asia Covid-19 Therapeutic Market Size by Type (2015-2020)
    10.4 Southeast Asia Covid-19 Therapeutic Market Size by Application (2015-2020)

11 India
    11.1 India Covid-19 Therapeutic Market Forecast (2019-2026)
    11.2 Covid-19 Therapeutic Key Players in India (2019-2020)
    11.3 India Covid-19 Therapeutic Market Size by Type (2015-2020)
    11.4 India Covid-19 Therapeutic Market Size by Application (2015-2020)

12 Central & South America
    12.1 Central & South America Covid-19 Therapeutic Market Forecast (2019-2026)
    12.2 Covid-19 Therapeutic Key Players in Central & South America (2019-2020)
    12.3 Central & South America Covid-19 Therapeutic Market Size by Type (2015-2020)
    12.4 Central & South America Covid-19 Therapeutic Market Size by Application (2015-2020)

13Key Players Profiles
    13.1 Cadila Healthcare
        13.1.1 Cadila Healthcare Company Details
        13.1.2 Cadila Healthcare Business Overview and Its Total Revenue
        13.1.3 Cadila Healthcare Covid-19 Therapeutic Introduction
        13.1.4 Cadila Healthcare Revenue in Covid-19 Therapeutic Business (2019-2020))
        13.1.5 Cadila Healthcare Recent Development
    13.2 Johnson & Johnson
        13.2.1 Johnson & Johnson Company Details
        13.2.2 Johnson & Johnson Business Overview and Its Total Revenue
        13.2.3 Johnson & Johnson Covid-19 Therapeutic Introduction
        13.2.4 Johnson & Johnson Revenue in Covid-19 Therapeutic Business (2019-2020))
        13.2.5 Johnson & Johnson Recent Development
    13.3 ImmunoPrecise
        13.3.1 ImmunoPrecise Company Details
        13.3.2 ImmunoPrecise Business Overview and Its Total Revenue
        13.3.3 ImmunoPrecise Covid-19 Therapeutic Introduction
        13.3.4 ImmunoPrecise Revenue in Covid-19 Therapeutic Business (2019-2020))
        13.3.5 ImmunoPrecise Recent Development
    13.4 Novartis
        13.4.1 Novartis Company Details
        13.4.2 Novartis Business Overview and Its Total Revenue
        13.4.3 Novartis Covid-19 Therapeutic Introduction
        13.4.4 Novartis Revenue in Covid-19 Therapeutic Business (2019-2020))
        13.4.5 Novartis Recent Development
    13.5 AstraZeneca
        13.5.1 AstraZeneca Company Details
        13.5.2 AstraZeneca Business Overview and Its Total Revenue
        13.5.3 AstraZeneca Covid-19 Therapeutic Introduction
        13.5.4 AstraZeneca Revenue in Covid-19 Therapeutic Business (2019-2020))
        13.5.5 AstraZeneca Recent Development
    13.6 Cipla
        13.6.1 Cipla Company Details
        13.6.2 Cipla Business Overview and Its Total Revenue
        13.6.3 Cipla Covid-19 Therapeutic Introduction
        13.6.4 Cipla Revenue in Covid-19 Therapeutic Business (2019-2020))
        13.6.5 Cipla Recent Development
    13.7 AbbVie
        13.7.1 AbbVie Company Details
        13.7.2 AbbVie Business Overview and Its Total Revenue
        13.7.3 AbbVie Covid-19 Therapeutic Introduction
        13.7.4 AbbVie Revenue in Covid-19 Therapeutic Business (2019-2020))
        13.7.5 AbbVie Recent Development
    13.8 Bayer
        13.8.1 Bayer Company Details
        13.8.2 Bayer Business Overview and Its Total Revenue
        13.8.3 Bayer Covid-19 Therapeutic Introduction
        13.8.4 Bayer Revenue in Covid-19 Therapeutic Business (2019-2020))
        13.8.5 Bayer Recent Development
    13.9 Regeneron Pharmaceuticals
        13.9.1 Regeneron Pharmaceuticals Company Details
        13.9.2 Regeneron Pharmaceuticals Business Overview and Its Total Revenue
        13.9.3 Regeneron Pharmaceuticals Covid-19 Therapeutic Introduction
        13.9.4 Regeneron Pharmaceuticals Revenue in Covid-19 Therapeutic Business (2019-2020))
        13.9.5 Regeneron Pharmaceuticals Recent Development
    13.10 Ascletis Pharma
        13.10.1 Ascletis Pharma Company Details
        13.10.2 Ascletis Pharma Business Overview and Its Total Revenue
        13.10.3 Ascletis Pharma Covid-19 Therapeutic Introduction
        13.10.4 Ascletis Pharma Revenue in Covid-19 Therapeutic Business (2019-2020))
        13.10.5 Ascletis Pharma Recent Development
    13.11 GlaxoSmithKline
        10.11.1 GlaxoSmithKline Company Details
        10.11.2 GlaxoSmithKline Business Overview and Its Total Revenue
        10.11.3 GlaxoSmithKline Covid-19 Therapeutic Introduction
        10.11.4 GlaxoSmithKline Revenue in Covid-19 Therapeutic Business (2019-2020))
        10.11.5 GlaxoSmithKline Recent Development
    13.12 Gilead Sciences
        10.12.1 Gilead Sciences Company Details
        10.12.2 Gilead Sciences Business Overview and Its Total Revenue
        10.12.3 Gilead Sciences Covid-19 Therapeutic Introduction
        10.12.4 Gilead Sciences Revenue in Covid-19 Therapeutic Business (2019-2020))
        10.12.5 Gilead Sciences Recent Development
    13.13 Pharmstandard
        10.13.1 Pharmstandard Company Details
        10.13.2 Pharmstandard Business Overview and Its Total Revenue
        10.13.3 Pharmstandard Covid-19 Therapeutic Introduction
        10.13.4 Pharmstandard Revenue in Covid-19 Therapeutic Business (2019-2020))
        10.13.5 Pharmstandard Recent Development
    13.14 Fujifilm Holdings
        10.14.1 Fujifilm Holdings Company Details
        10.14.2 Fujifilm Holdings Business Overview and Its Total Revenue
        10.14.3 Fujifilm Holdings Covid-19 Therapeutic Introduction
        10.14.4 Fujifilm Holdings Revenue in Covid-19 Therapeutic Business (2019-2020))
        10.14.5 Fujifilm Holdings Recent Development
    13.15 Zhejiang Hisun Pharmaceutical Co. Ltd
        10.15.1 Zhejiang Hisun Pharmaceutical Co. Ltd Company Details
        10.15.2 Zhejiang Hisun Pharmaceutical Co. Ltd Business Overview and Its Total Revenue
        10.15.3 Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Therapeutic Introduction
        10.15.4 Zhejiang Hisun Pharmaceutical Co. Ltd Revenue in Covid-19 Therapeutic Business (2019-2020))
        10.15.5 Zhejiang Hisun Pharmaceutical Co. Ltd Recent Development
    13.16 Roche
        10.16.1 Roche Company Details
        10.16.2 Roche Business Overview and Its Total Revenue
        10.16.3 Roche Covid-19 Therapeutic Introduction
        10.16.4 Roche Revenue in Covid-19 Therapeutic Business (2019-2020))
        10.16.5 Roche Recent Development
    13.17 Sanofi
        10.17.1 Sanofi Company Details
        10.17.2 Sanofi Business Overview and Its Total Revenue
        10.17.3 Sanofi Covid-19 Therapeutic Introduction
        10.17.4 Sanofi Revenue in Covid-19 Therapeutic Business (2019-2020))
        10.17.5 Sanofi Recent Development
    13.18 Pfizer
        10.18.1 Pfizer Company Details
        10.18.2 Pfizer Business Overview and Its Total Revenue
        10.18.3 Pfizer Covid-19 Therapeutic Introduction
        10.18.4 Pfizer Revenue in Covid-19 Therapeutic Business (2019-2020))
        10.18.5 Pfizer Recent Development

14 Market Dynamics
    14.1 Drivers
    14.2 Challenges
    14.3 Porter’s Five Forces Analysis
    14.4 Market Ecosystem and Value Chain Analysis

15 Key Findings in This Report
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Disclaimer
    15.3 Author Details

List of Tables Table 1. Covid-19 Therapeutic Key Market Segments Table 2. Key Players Covered: Ranking by Covid-19 Therapeutic Revenue Table 3. Ranking of Global Top Covid-19 Therapeutic Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Covid-19 Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Immunotherapy Table 6. Key Players of Life Support Table 7. Key Players of Antiviral Medicine Table 8. Key Players of Plasma Therapy Table 9. Key Players of Others Table 10. COVID-19 Impact Global Market: (Four Covid-19 Therapeutic Market Size Forecast Scenarios) Table 11. Opportunities and Trends for Covid-19 Therapeutic Players in the COVID-19 Landscape Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 13. Key Regions/Countries Measures against Covid-19 Impact Table 14. Proposal for Covid-19 Therapeutic Players to Combat Covid-19 Impact Table 15. Global Covid-19 Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 16. Global Covid-19 Therapeutic Market Size by Regions (US$ Million): 2020 VS 2026 Table 17. Global Covid-19 Therapeutic Market Size by Regions (US$ Million): 2020 VS 2026 Table 18. Global Covid-19 Therapeutic Market Share by Regions 2019-2026 Table 19. Market Top Trends Table 20. Market Use Cases Table 21. Global Covid-19 Therapeutic Revenue by Players (2019-2020) (Million US$) Table 22. Global Covid-19 Therapeutic Market Share by Players (2019-2020) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Covid-19 Therapeutic Product Solution and Service Table 25. Date of Enter into Covid-19 Therapeutic Market Table 26. Global Key Players Covid-19 Therapeutic Funding/Investment Analysis (Million USD) Table 27. Global Key Players Covid-19 Therapeutic Valuation & Market Capitalization (Million USD) Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global Covid-19 Therapeutic Market Size by Type (2019-2026) (Million US$) Table 30. Global Covid-19 Therapeutic Market Size Share by Type (2019-2026) Table 31. Global Covid-19 Therapeutic Market Size by Application (2019-2026) (Million US$) Table 32. Global Covid-19 Therapeutic Market Size Share by Application (2019-2026) Table 33. North America Key Players Covid-19 Therapeutic Revenue (2019-2020) (Million US$) Table 34. North America Key Players Covid-19 Therapeutic Market Share (2019-2020) Table 35. North America Covid-19 Therapeutic Market Size by Type (2019-2026) (Million US$) Table 36. North America Covid-19 Therapeutic Market Share by Type (2019-2026) Table 37. North America Covid-19 Therapeutic Market Size by Application (2019-2026) (Million US$) Table 38. North America Covid-19 Therapeutic Market Share by Application (2019-2026) Table 39. Europe Key Players Covid-19 Therapeutic Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Covid-19 Therapeutic Market Share (2019-2020) Table 41. Europe Covid-19 Therapeutic Market Size by Type (2019-2026) (Million US$) Table 42. Europe Covid-19 Therapeutic Market Share by Type (2019-2026) Table 43. Europe Covid-19 Therapeutic Market Size by Application (2019-2026) (Million US$) Table 44. Europe Covid-19 Therapeutic Market Share by Application (2019-2026) Table 45. China Key Players Covid-19 Therapeutic Revenue (2019-2020) (Million US$) Table 46. China Key Players Covid-19 Therapeutic Market Share (2019-2020) Table 47. China Covid-19 Therapeutic Market Size by Type (2019-2026) (Million US$) Table 48. China Covid-19 Therapeutic Market Share by Type (2019-2026) Table 49. China Covid-19 Therapeutic Market Size by Application (2019-2026) (Million US$) Table 50. China Covid-19 Therapeutic Market Share by Application (2019-2026) Table 51. Japan Key Players Covid-19 Therapeutic Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Covid-19 Therapeutic Market Share (2019-2020) Table 53. Japan Covid-19 Therapeutic Market Size by Type (2019-2026) (Million US$) Table 54. Japan Covid-19 Therapeutic Market Share by Type (2019-2026) Table 55. Japan Covid-19 Therapeutic Market Size by Application (2019-2026) (Million US$) Table 56. Japan Covid-19 Therapeutic Market Share by Application (2019-2026) Table 57. Southeast Asia Key Players Covid-19 Therapeutic Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Covid-19 Therapeutic Market Share (2019-2020) Table 59. Southeast Asia Covid-19 Therapeutic Market Size by Type (2019-2026) (Million US$) Table 60. Southeast Asia Covid-19 Therapeutic Market Share by Type (2019-2026) Table 61. Southeast Asia Covid-19 Therapeutic Market Size by Application (2019-2026) (Million US$) Table 62. Southeast Asia Covid-19 Therapeutic Market Share by Application (2019-2026) Table 63. India Key Players Covid-19 Therapeutic Revenue (2019-2020) (Million US$) Table 64. India Key Players Covid-19 Therapeutic Market Share (2019-2020) Table 65. India Covid-19 Therapeutic Market Size by Type (2019-2026) (Million US$) Table 66. India Covid-19 Therapeutic Market Share by Type (2019-2026) Table 67. India Covid-19 Therapeutic Market Size by Application (2019-2026) (Million US$) Table 68. India Covid-19 Therapeutic Market Share by Application (2019-2026) Table 69. Central & South America Key Players Covid-19 Therapeutic Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Covid-19 Therapeutic Market Share (2019-2020) Table 71. Central & South America Covid-19 Therapeutic Market Size by Type (2019-2026) (Million US$) Table 72. Central & South America Covid-19 Therapeutic Market Share by Type (2019-2026) Table 73. Central & South America Covid-19 Therapeutic Market Size by Application (2019-2026) (Million US$) Table 74. Central & South America Covid-19 Therapeutic Market Share by Application (2019-2026) Table 75. Cadila Healthcare Company Details Table 76. Cadila Healthcare Business Overview Table 77. Cadila Healthcare Product Table 78. Company Description and Business Overview Table 79. Cadila Healthcare Covid-19 Therapeutic Product Table 80. Cadila Healthcare Revenue in Covid-19 Therapeutic Business 2019 and 2020 (Million US$) Table 81. Cadila Healthcare Recent Development Table 82. Johnson & Johnson Company Details Table 83. Johnson & Johnson Business Overview Table 84. Johnson & Johnson Product Table 85. Company Description and Business Overview Table 86. Johnson & Johnson Covid-19 Therapeutic Product Table 87. Johnson & Johnson Revenue in Covid-19 Therapeutic Business 2019 and 2020 (Million US$) Table 88. Johnson & Johnson Recent Development Table 89. ImmunoPrecise Company Details Table 90. ImmunoPrecise Business Overview Table 91. ImmunoPrecise Product Table 92. Company Description and Business Overview Table 93. ImmunoPrecise Covid-19 Therapeutic Product Table 94. ImmunoPrecise Revenue in Covid-19 Therapeutic Business 2019 and 2020 (Million US$) Table 95. ImmunoPrecise Recent Development Table 96. Novartis Company Details Table 97. Novartis Business Overview Table 98. Novartis Product Table 99. Company Description and Business Overview Table 100. Novartis Covid-19 Therapeutic Product Table 101. Novartis Revenue in Covid-19 Therapeutic Business 2019 and 2020 (Million US$) Table 102. Novartis Recent Development Table 103. AstraZeneca Company Details Table 104. AstraZeneca Business Overview Table 105. AstraZeneca Product Table 106. Company Description and Business Overview Table 107. AstraZeneca Covid-19 Therapeutic Product Table 108. AstraZeneca Revenue in Covid-19 Therapeutic Business 2019 and 2020 (Million US$) Table 109. AstraZeneca Recent Development Table 110. Cipla Company Details Table 111. Cipla Business Overview Table 112. Cipla Product Table 113. Company Description and Business Overview Table 114. Cipla Covid-19 Therapeutic Product Table 115. Cipla Revenue in Covid-19 Therapeutic Business 2019 and 2020 (Million US$) Table 116. Cipla Recent Development Table 117. AbbVie Company Details Table 118. AbbVie Business Overview Table 119. AbbVie Product Table 120. Company Description and Business Overview Table 121. AbbVie Covid-19 Therapeutic Product Table 122. AbbVie Revenue in Covid-19 Therapeutic Business 2019 and 2020 (Million US$) Table 123. AbbVie Recent Development Table 124. Bayer Business Overview Table 125. Bayer Product Table 126. Bayer Company Details Table 127. Company Description and Business Overview Table 128. Bayer Covid-19 Therapeutic Product Table 129. Bayer Revenue in Covid-19 Therapeutic Business 2019 and 2020 (Million US$) Table 130. Bayer Recent Development Table 131. Regeneron Pharmaceuticals Company Details Table 132. Regeneron Pharmaceuticals Business Overview Table 133. Regeneron Pharmaceuticals Product Table 134. Company Description and Business Overview Table 135. Regeneron Pharmaceuticals Covid-19 Therapeutic Product Table 136. Regeneron Pharmaceuticals Revenue in Covid-19 Therapeutic Business 2019 and 2020 (Million US$) Table 137. Regeneron Pharmaceuticals Recent Development Table 138. Ascletis Pharma Company Details Table 139. Ascletis Pharma Business Overview Table 140. Ascletis Pharma Product Table 141. Company Description and Business Overview Table 142. Ascletis Pharma Covid-19 Therapeutic Product Table 143. Ascletis Pharma Revenue in Covid-19 Therapeutic Business 2019 and 2020 (Million US$) Table 144. Ascletis Pharma Recent Development Table 145. GlaxoSmithKline Company Details Table 146. GlaxoSmithKline Business Overview Table 147. GlaxoSmithKline Product Table 148. Company Description and Business Overview Table 149. GlaxoSmithKline Covid-19 Therapeutic Product Table 150. GlaxoSmithKline Revenue in Covid-19 Therapeutic Business 2019 and 2020 (Million US$) Table 151. GlaxoSmithKline Recent Development Table 152. Gilead Sciences Company Details Table 153. Gilead Sciences Business Overview Table 154. Gilead Sciences Product Table 155. Company Description and Business Overview Table 156. Gilead Sciences Covid-19 Therapeutic Product Table 157. Gilead Sciences Revenue in Covid-19 Therapeutic Business 2019 and 2020 (Million US$) Table 158. Gilead Sciences Recent Development Table 159. Pharmstandard Company Details Table 160. Pharmstandard Business Overview Table 161. Pharmstandard Product Table 162. Company Description and Business Overview Table 163. Pharmstandard Covid-19 Therapeutic Product Table 164. Pharmstandard Revenue in Covid-19 Therapeutic Business 2019 and 2020 (Million US$) Table 165. Pharmstandard Recent Development Table 166. Fujifilm Holdings Company Details Table 167. Fujifilm Holdings Business Overview Table 168. Fujifilm Holdings Product Table 169. Company Description and Business Overview Table 170. Fujifilm Holdings Covid-19 Therapeutic Product Table 171. Fujifilm Holdings Revenue in Covid-19 Therapeutic Business 2019 and 2020 (Million US$) Table 172. Fujifilm Holdings Recent Development Table 173. Zhejiang Hisun Pharmaceutical Co. Ltd Company Details Table 174. Zhejiang Hisun Pharmaceutical Co. Ltd Business Overview Table 175. Zhejiang Hisun Pharmaceutical Co. Ltd Product Table 176. Company Description and Business Overview Table 177. Zhejiang Hisun Pharmaceutical Co. Ltd Covid-19 Therapeutic Product Table 178. Zhejiang Hisun Pharmaceutical Co. Ltd Revenue in Covid-19 Therapeutic Business 2019 and 2020 (Million US$) Table 179. Zhejiang Hisun Pharmaceutical Co. Ltd Recent Development Table 180. Roche Company Details Table 181. Roche Business Overview Table 182. Roche Product Table 183. Company Description and Business Overview Table 184. Roche Covid-19 Therapeutic Product Table 185. Roche Revenue in Covid-19 Therapeutic Business 2019 and 2020 (Million US$) Table 186. Roche Recent Development Table 187. Sanofi Company Details Table 188. Sanofi Business Overview Table 189. Sanofi Product Table 190. Company Description and Business Overview Table 191. Sanofi Covid-19 Therapeutic Product Table 192. Sanofi Revenue in Covid-19 Therapeutic Business 2019 and 2020 (Million US$) Table 193. Sanofi Recent Development Table 194. Pfizer Company Details Table 195. Pfizer Business Overview Table 196. Pfizer Product Table 197. Company Description and Business Overview Table 198. Pfizer Covid-19 Therapeutic Product Table 199. Pfizer Revenue in Covid-19 Therapeutic Business 2019 and 2020 (Million US$) Table 200. Pfizer Recent Development Table 201. Company Description and Business Overview Table 202. Company Description and Business Overview Table 203. Company Description and Business Overview Table 204. Company Description and Business Overview Table 205. Company Description and Business Overview Table 206. Company Description and Business Overview Table 207. Company Description and Business Overview Table 208. Company Description and Business Overview Table 209. Company Description and Business Overview Table 210. Company Description and Business Overview Table 211. Company Description and Business Overview Table 212. Company Description and Business Overview Table 213. Company Description and Business Overview Table 214. Company Description and Business Overview Table 215. Company Description and Business Overview Table 216. Company Description and Business Overview Table 217. Company Description and Business Overview Table 218. Company Description and Business Overview Table 219. Company Description and Business Overview Table 220. Company Description and Business Overview Table 221. Company Description and Business Overview Table 222. Company Description and Business Overview Table 223. Key Drivers: Impact Analysis (2021-2026) Table 224. Key Opportunities Table 225. Key Challenges Table 226. Research Programs/Design for This Report Table 227. Key Data Information from Secondary Sources Table 228. Key Data Information from Primary Sources List of Figures Figure 1. Global Covid-19 Therapeutic Market Share by Type: 2020 VS 2026 Figure 2. Immunotherapy Features Figure 3. Life Support Features Figure 4. Antiviral Medicine Features Figure 5. Plasma Therapy Features Figure 6. Others Features Figure 7. Global Covid-19 Therapeutic Market Share by Application: 2020 VS 2026 Figure 8. Children Case Studies Figure 9. Adult Case Studies Figure 10. Covid-19 Therapeutic Report Years Considered Figure 11. Global Covid-19 Therapeutic and Growth Rate (2019-2026) (Million US$) Figure 12. Global Covid-19 Therapeutic Market Share by Regions (2019-2026) Figure 13. Global Covid-19 Therapeutic Market Share by Players in 2019 Figure 14. Global Covid-19 Therapeutic Market Size Market Share by Type (2019-2026) Figure 15. Global Covid-19 Therapeutic Market Size Market Share by Application (2019-2026) Figure 16. North America Covid-19 Therapeutic Market Size YoY Growth (2019-2026) (Million US$) Figure 17. Europe Covid-19 Therapeutic Market Size YoY Growth (2019-2026) (Million US$) Figure 18. China Covid-19 Therapeutic Market Size YoY Growth (2019-2026) (Million US$) Figure 19. Japan Covid-19 Therapeutic Market Size YoY Growth (2019-2026) (Million US$) Figure 20. Southeast Asia Covid-19 Therapeutic Market Size YoY Growth (2019-2026) (Million US$) Figure 21. India Covid-19 Therapeutic Market Size YoY Growth (2019-2026) (Million US$) Figure 22. Central & South America Covid-19 Therapeutic Market Size YoY Growth (2019-2026) (Million US$) Figure 23. Bottom-up and Top-down Approaches for This Report Figure 24. Data Triangulation Figure 25. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Media and Technology Reports

Global Insurance for Recovery Work in Covid-19 Market Growth (Status and Outlook) 2020-2025

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifti...

Global Insurance for Against Covid-19 Market Growth (Status and Outlook) 2020-2025

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifti...

Global Microwave Energy Fuel Market Growth (Status and Outlook) 2020-2025

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifti...

Global Cold Storage Construction Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Market Overview The global Cold Storage Construction market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.6% in the forecast period of 2020 to 2025 and will expected to reach USD 8566.7 million by 20...

Global Norilsk Nickel Market 2020 by Company, Regions, Type and Application, Forecast to 2025

Market Overview The global Norilsk Nickel market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx ...

Other Reports by QY Research

COVID-19 Impact on Monocalcium Phosphate (MCP) Market, Global Research Reports 2020-2021

This report covers market size and forecasts of Monocalcium Phosphate (MCP), including the following market information: Global Monocalcium Phosphate (MCP) Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT) Global Mon...

COVID-19 Impact on Modulator Drivers Market, Global Research Reports 2020-2021

This report covers market size and forecasts of Modulator Drivers, including the following market information: Global Modulator Drivers Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units) Global Modulator Drivers Ma...

COVID-19 Impact on Mobile Data Protection Solutions Market, Global Research Reports 2020-2021

This report covers market size and forecasts of Mobile Data Protection Solutions, including the following market information: Global Mobile Data Protection Solutions Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) Global Mo...

COVID-19 Impact on Methyl Ethyl Ketoxime (MEKO) Market, Global Research Reports 2020-2021

This report covers market size and forecasts of Methyl Ethyl Ketoxime (MEKO), including the following market information: Global Methyl Ethyl Ketoxime (MEKO) Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT) Global M...

COVID-19 Impact on Maritime Satellite Communications Market, Global Research Reports 2020-2021

This report covers market size and forecasts of Maritime Satellite Communications, including the following market information: Global Maritime Satellite Communications Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) Global ...

Publisher: QY Research